Methanandamide: Difference between revisions
Appearance
Content deleted Content added
m Bot: Migrating 1 interwiki links, now provided by Wikidata on d:q6553887 |
No edit summary |
||
Line 43: | Line 43: | ||
{{Cannabinoids}} |
{{Cannabinoids}} |
||
{{Cannabinoidergics}} |
|||
[[Category:Fatty acid amides]] |
[[Category:Fatty acid amides]] |
Revision as of 22:19, 19 November 2014
Names | |
---|---|
IUPAC name
(5Z,8Z,11Z,14Z)-N-[(1R)-2-hydroxy-1-methylethyl]icosa-5,8,11,14-tetraenamide
| |
Other names
AM-356; Arachidonyl-1'-hydroxy-2'-propylamide
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
| |
| |
Properties | |
C23H39NO2 | |
Molar mass | 361.570 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Methanandamide (AM-356) is a synthetically created stable chiral analog of anandamide.[1] Its effects have been observed to act on the cannabinoid receptors (specifically on CB1 receptors, which are part of the central nervous system) found in different organisms such as mammals, fish, and certain invertebrates (e.g. Hydra).
References
- ^ Abadji, V; et al. (1994). "(R)-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability". Journal of Medical Chemistry. 37 (12): 1889–93. doi:10.1021/jm00038a020. PMID 8021930.
{{cite journal}}
: Explicit use of et al. in:|first=
(help)